Notably, a comprehensive meta‐analysis of 16 858 cases of genetic MPO deficiency and 21 756 control subjects revealed that lower MPO expression is associated with an overall reduced cancer risk in both solid and haematological cancers.42 The gene discussed is MPO; the disease is cancer.